EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting and engineering long non-coding RNAs for cancer therapy

Michela Coan, Simon Haefliger, Samir Ounzain, Rory Johnson

Nature Reviews Genetics · 2024-08 · 25 (8) · 578-595

DOI: 10.1038/s41576-024-00693-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nature Reviews Genetics, online erschienen am 29.02.2024. Verfasst von Michela Coan und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology and Environmental Science, University College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 203-mal zitiert (Crossref) und nennt 256 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA therapeutics (RNATx) aim to treat diseases, including cancer, by targeting or employing RNA molecules for therapeutic purposes. Amongst the most promising targets are long non-coding RNAs (lncRNAs), which regulate oncogenic molecular networks in a cell type-restricted manner. lncRNAs are distinct from protein-coding genes in important ways that increase their therapeutic potential yet also present hurdles to conventional clinical development. Advances in genome editing, oligonucleotide chemistry, multi-omics and RNA engineering are paving the way for efficient and cost-effective lncRNA-focused drug discovery pipelines. In this Review, we present the emerging field of lncRNA therapeutics for oncology, with emphasis on the unique strengths and challenges of lncRNAs within the broader RNATx framework. We outline the necessary steps for lncRNA therapeutics to deliver effective, durable, tolerable and personalized treatments for cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsRNA, Long NoncodingHumansAnimalsGene EditingGenetic EngineeringGenetic Therapy

Substanzen

RNA, Long Noncoding

Autor:innen und Institutionen

  • School of Biology and Environmental Science, University College Dublin, Dublin, Ireland.
  • Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Dublin, Ireland.
  • School of Medicine, University College Dublin, Dublin, Ireland.
  • Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • HAYA Therapeutics, Lausanne, Vaud, Switzerland.

Zitieren

APA

Coan, M., Haefliger, S., Ounzain, S., & Johnson, R. (2024). Targeting and engineering long non-coding RNAs for cancer therapy. Nature Reviews Genetics, 25(8), 578-595. https://doi.org/10.1038/s41576-024-00693-2

Vancouver

Coan M, Haefliger S, Ounzain S, Johnson R. Targeting and engineering long non-coding RNAs for cancer therapy. Nature Reviews Genetics. 2024;25(8):578-595. doi:10.1038/s41576-024-00693-2

BibTeX
@article{Coan2024,
  author = {Coan, Michela and Haefliger, Simon and Ounzain, Samir and Johnson, Rory},
  title = {Targeting and engineering long non-coding RNAs for cancer therapy},
  journal = {Nature Reviews Genetics},
  year = {2024},
  volume = {25},
  number = {8},
  pages = {578--595},
  doi = {10.1038/s41576-024-00693-2}
}
Kostenlos starten →